By Nov. 19, 2018 10:55 a.m.
ET What role cannabis should play in medicine is still an open question.
However, there is no doubt that mentioning the once-forbidden leaf can be a miracle cure for a biotech’s stock price.
Tiny Akers Biosciences on Monday announced an update to a strategic review which began earlier this month.
Akers said the process “will consider a range of potential strategic alternatives including, but not limited to, business combinations in alternative sectors including cannabis related industries.”
...
READ MORE (Wall Street Journal)
- Must Watch these Stocks Earnings: Akers Biosciences Inc (NASDAQ:AKER), Cimarex ...StandardOracle
- Akers Biosciences (AKER) Stock: Flying On Cannabis News!CNA Finance
- Akers Bio up 76% premarket on potential foray into cannabis spaceSeeking Alpha
- Akers Biosciences leads Healthcare gainers; Sonoma Pharmaceuticals leads the ...Seeking Alpha
- Akers Biosciences Exploring Potential Business Combinations in Alternative ...Nasdaq
- Get Into Akers Biosciences, Inc. (AKER) For The Right ReasonsThe RNS Daily
- Akers Biosciences, Inc. (AKER) closed at $1.23, 1 year low of 26.02% and a 1 ...Stock Market Floor (press release)
- Investment Research Analysts Opinion: Akers Biosciences, Inc. (AKER), Avinger ...Analyst Journal
- Akers Biosciences Inc (NASDAQ:AKER) Sees Large Decrease in Short InterestBaseball Daily News
